INTRODUCTION: Antiretroviral treatment (ART) coverage is rapidly expanding in sub-Saharan Africa (SSA). Based on the effect of ART on survival of HIV-infected people and HIV transmission, the age composition of the HIV epidemic in the region is expected to change in the coming decades. We quantify the change in the age composition of HIV-infected people in all countries in SSA. METHODS: We used STDSIM, a stochastic microsimulation model, and developed an approach to represent HIV prevalence and treatment coverage in 43 countries in SSA, using publicly available data. We predict future trends in HIV prevalence and total number of HIV-infected people aged 15-49 years and 50 years or older for different ART coverage levels. RESULTS: We show that, if treatment coverage continues to increase at present rates, the total number of HIV-infected people aged 50 years or older will nearly triple over the coming years: from 3.1 million in 2011 to 9.1 million in 2040, dramatically changing the age composition of the HIV epidemic in SSA. In 2011, about one in seven HIV-infected people was aged 50 years or older; in 2040, this ratio will be larger than one in four. CONCLUSION: The HIV epidemic in SSA is rapidly ageing, implying changing needs and demands in many social sectors, including health, social care, and old-age pension systems. Health policymakers need to anticipate the impact of the changing HIV age composition in their planning for future capacity in these systems.
INTRODUCTION: Antiretroviral treatment (ART) coverage is rapidly expanding in sub-Saharan Africa (SSA). Based on the effect of ART on survival of HIV-infected people and HIV transmission, the age composition of the HIV epidemic in the region is expected to change in the coming decades. We quantify the change in the age composition of HIV-infected people in all countries in SSA. METHODS: We used STDSIM, a stochastic microsimulation model, and developed an approach to represent HIV prevalence and treatment coverage in 43 countries in SSA, using publicly available data. We predict future trends in HIV prevalence and total number of HIV-infected people aged 15-49 years and 50 years or older for different ART coverage levels. RESULTS: We show that, if treatment coverage continues to increase at present rates, the total number of HIV-infected people aged 50 years or older will nearly triple over the coming years: from 3.1 million in 2011 to 9.1 million in 2040, dramatically changing the age composition of the HIV epidemic in SSA. In 2011, about one in seven HIV-infected people was aged 50 years or older; in 2040, this ratio will be larger than one in four. CONCLUSION: The HIV epidemic in SSA is rapidly ageing, implying changing needs and demands in many social sectors, including health, social care, and old-age pension systems. Health policymakers need to anticipate the impact of the changing HIV age composition in their planning for future capacity in these systems.
Authors: Sue Napierala Mavedzenge; Rick Olson; Aoife M Doyle; John Changalucha; David A Ross Journal: J Adolesc Health Date: 2011-06-12 Impact factor: 5.012
Authors: A Buvé; M Caraël; R J Hayes; B Auvert; B Ferry; N J Robinson; S Anagonou; L Kanhonou; M Laourou; S Abega; E Akam; L Zekeng; J Chege; M Kahindo; N Rutenberg; F Kaona; R Musonda; T Sukwa; L Morison; H A Weiss; M Laga Journal: AIDS Date: 2001-08 Impact factor: 4.177
Authors: Nico J D Nagelkerke; Prabhat Jha; Sake J de Vlas; Eline L Korenromp; Stephen Moses; James F Blanchard; Frank A Plummer Journal: Bull World Health Organ Date: 2002 Impact factor: 9.408
Authors: Stephenson Musiime; Fred Muhairwe; Alfred Rutagengwa; Eugene Mutimura; Kathryn Anastos; Donald R Hoover; Shi Qiuhu; Elizaphane Munyazesa; Ivan Emile; Annette Uwineza; Ethan Cowan Journal: PLoS One Date: 2011-11-17 Impact factor: 3.240
Authors: Kobus Herbst; Matthew Law; Pascal Geldsetzer; Frank Tanser; Guy Harling; Till Bärnighausen Journal: Curr Opin HIV AIDS Date: 2015-11 Impact factor: 4.283
Authors: Chris T Longenecker; Emmy Okello; Peter Lwabi; Marco A Costa; Daniel I Simon; Robert A Salata Journal: J Acquir Immune Defic Syndr Date: 2014-02-01 Impact factor: 3.731
Authors: Joshua O Akinyemi; Babatunde O Ogunbosi; Adetona S Fayemiwo; Olubukola A Adesina; Michael Obaro; Modupe A Kuti; Olutosin A Awolude; David O Olaleye; Isaac F Adewole Journal: Afr Health Sci Date: 2017-06 Impact factor: 0.927
Authors: Samson Okello; Michael Kanyesigye; Winnie R Muyindike; Brian Herb Annex; Peter W Hunt; Sebastien Haneuse; Mark Jacob Siedner Journal: J Hypertens Date: 2015-10 Impact factor: 4.844
Authors: F Xavier Gómez-Olivé; Livia Montana; Ryan G Wagner; Chodziwadziwa W Kabudula; Julia K Rohr; Kathleen Kahn; Till Bärnighausen; Mark Collinson; David Canning; Thomas Gaziano; Joshua A Salomon; Collin F Payne; Alisha Wade; Stephen M Tollman; Lisa Berkman Journal: Int J Epidemiol Date: 2018-06-01 Impact factor: 7.196
Authors: Jennifer Manne-Goehler; Livia Montana; Francesc Xavier Gómez-Olivé; Julia Rohr; Guy Harling; Ryan G Wagner; Alisha Wade; Chodziwadziwa W Kabudula; Pascal Geldsetzer; Kathleen Kahn; Stephen Tollman; Lisa F Berkman; Till W Bärnighausen; Thomas A Gaziano Journal: J Acquir Immune Defic Syndr Date: 2017-08-15 Impact factor: 3.731